Prognostic role of circulating tumor cells in patients with EGFR‐mutated or ALK‐rearranged non‐small cell lung cancer

BACKGROUND: Circulating tumor cell (CTC) counts at baseline and follow‐up are an independent prognostic factor in patients receiving standard chemotherapy for non‐small cell lung cancer (NSCLC). This study further explored the role of CTCs in EGFR‐mutated and ALK‐rearranged NSCLC patients administer...

Descripción completa

Detalles Bibliográficos
Autores principales: Tong, Bing, Xu, Yan, Zhao, Jing, Chen, Minjiang, Zhong, Wei, Xing, Jia, Wang, Mengzhao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5928386/
https://www.ncbi.nlm.nih.gov/pubmed/29582563
http://dx.doi.org/10.1111/1759-7714.12631

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5928386/
https://www.ncbi.nlm.nih.gov/pubmed/29582563
http://dx.doi.org/10.1111/1759-7714.12631

Ejemplares similares